Literature DB >> 23670229

The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis.

David F Schaeffer1, Lay Lay Win, Sara Hafezi-Bakhtiari, Maria Cino, Gideon M Hirschfield, Hala El-Zimaity.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) associated with primary sclerosing cholangitis (PSC) is reported to be mild and prone to right-side predominance with rectal sparing. However, no dedicated studies evaluating patterns of presentation of liver disease with respect to IBD are available.
METHODS: We performed a detailed histological examination of the colonic biopsies in the context of PSC, identifying 97 patients [89 with ulcerative colitis and ten with Crohn's disease (CD)] stratified into two groups, based on their initial disease presentation: hepatic/biliary (group 1-PSC-IBD; n=56) versus colonic (group 2-IBD-PSC; n=41).
RESULTS: Inflammatory bowel disease that preceded PSC had a tendency to have a "pan-colitis" distribution; this group included all patients with CD. Inflammatory bowel disease diagnosis that followed PSC presentation was more likely to be right-sided, sparing the descending, sigmoid and rectal regions (p=0.002). In both groups, colitis was mild with focal deep plasmacytosis and occasional mild cryptitis. Active cryptitis with crypt abscesses, surface erosion and ulceration were not identified in any of the patients.
CONCLUSION: Colitis associated with PSC shows mild disease activity and the colitis pattern is associated with disease presentation, i.e. colitis preceding PSC (IBD-PSC cohort) typically have a pancolitic distribution, while colitis following PSC (PSC-IBD cohort) demonstrates right-sided predominance. Awareness by pathologists and clinicians of these patterns of inflammatory bowel disease is important and of use in directing appropriate investigations for patients.

Entities:  

Mesh:

Year:  2013        PMID: 23670229     DOI: 10.1007/s10620-013-2697-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.

Authors:  Kirsten Boonstra; Karel J van Erpecum; Karin M J van Nieuwkerk; Joost P H Drenth; Alexander C Poen; Ben J M Witteman; Hans A R E Tuynman; Ulrich Beuers; Cyriel Y Ponsioen
Journal:  Inflamm Bowel Dis       Date:  2012-03-08       Impact factor: 5.325

Review 2.  Genetics in primary sclerosing cholangitis.

Authors:  Trine Folseraas; Espen Melum; Andre Franke; Tom H Karlsen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-12       Impact factor: 3.043

3.  Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  Hitoshi Sano; Takahiro Nakazawa; Tomoaki Ando; Kazuki Hayashi; Itaru Naitoh; Fumihiro Okumura; Katsuyuki Miyabe; Michihiro Yoshida; Satoru Takahashi; Hirotaka Ohara; Takashi Joh
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-03       Impact factor: 7.027

4.  Primary sclerosing cholangitis: a long-term follow-up study.

Authors:  E Aadland; E Schrumpf; O Fausa; K Elgjo; A Heilo; T Aakhus; E Gjone
Journal:  Scand J Gastroenterol       Date:  1987-08       Impact factor: 2.423

5.  Primary sclerosing cholangitis: an experience from India.

Authors:  R Kochhar; M K Goenka; K Das; B Nagi; D K Bhasin; Y K Chawla; K Vaiphei; K Singh; J B Dilawari
Journal:  J Gastroenterol Hepatol       Date:  1996-05       Impact factor: 4.029

6.  Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.

Authors:  U Broomé; R Olsson; L Lööf; G Bodemar; R Hultcrantz; A Danielsson; H Prytz; H Sandberg-Gertzén; S Wallerstedt; G Lindberg
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

7.  Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.

Authors:  C Penna; R Dozois; W Tremaine; W Sandborn; N LaRusso; C Schleck; D Ilstrup
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

8.  Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.

Authors:  Mee Joo; Paula Abreu-e-Lima; Francis Farraye; Timothy Smith; Prabhakar Swaroop; Laura Gardner; Gregory Y Lauwers; Robert Daniel Odze
Journal:  Am J Surg Pathol       Date:  2009-06       Impact factor: 6.394

9.  Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver.

Authors:  A Escorsell; A Parés; J Rodés; J A Solís-Herruzo; M Miras; E de la Morena
Journal:  J Hepatol       Date:  1994-11       Impact factor: 25.083

10.  Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients.

Authors:  Hajime Takikawa; Yoriyuki Takamori; Atsushi Tanaka; Hiroko Kurihara; Yasuni Nakanuma
Journal:  Hepatol Res       Date:  2004-07       Impact factor: 4.288

View more
  9 in total

1.  Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.

Authors:  Noa Krugliak Cleveland; David T Rubin; John Hart; Christopher R Weber; Katherine Meckel; Anthony L Tran; Arthur S Aelvoet; Isabella Pan; Alex Gonsalves; John Nick Gaetano; Kelli M Williams; Kristen Wroblewski; Bana Jabri; Joel Pekow
Journal:  Clin Gastroenterol Hepatol       Date:  2017-07-26       Impact factor: 11.382

Review 2.  Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.

Authors:  A Boudewijn de Vries; Marcel Janse; Hans Blokzijl; Rinse K Weersma
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 3.  The IBD and PSC Phenotypes of PSC-IBD.

Authors:  Amanda Ricciuto; Binita M Kamath; Anne M Griffiths
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

Review 4.  Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?

Authors:  Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Hitoshi Sano; Katsuyuki Miyabe; Shuya Shimizu; Takashi Joh
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

5.  Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.

Authors:  James H Tabibian; Ahmad H Ali; Keith D Lindor
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-05

6.  Impact of transjugular intrahepatic portosystemic shunt on post-colectomy complications in patients with ulcerative colitis and primary sclerosing cholangitis.

Authors:  Gursimran Kochhar; Udayakumar Navaneethan; Jose Mari Parungao; Jason Hartman; Ranjan Gupta; Rocio Lopez; Arthur J McCullough; Baljiendra Kapoor; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-12-16

7.  Newly Diagnosed Colonic Adenocarcinoma: The Presenting Sign in a Young Woman with Undiagnosed Crohn's Disease in the Absence of Primary Sclerosing Cholangitis and a Normal Microsatellite Instability Profile.

Authors:  Brett Matthew Lowenthal; Ann M Ponsford Tipps
Journal:  Case Rep Pathol       Date:  2017-01-31

Review 8.  Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.

Authors:  Carolina Palmela; Farhad Peerani; Daniel Castaneda; Joana Torres; Steven H Itzkowitz
Journal:  Gut Liver       Date:  2018-01-15       Impact factor: 4.519

Review 9.  Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.

Authors:  Stefano Mazza; Sara Soro; Maria Chiara Verga; Biagio Elvo; Francesca Ferretti; Fabrizio Cereatti; Andrea Drago; Roberto Grassia
Journal:  World J Hepatol       Date:  2021-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.